A new drug called WNTinib can delay the growth of tumors and improve survival in hepatoblastoma, a type of liver cancer that ...

Surgery is rarely indicated in these circumstances. Infrequently, benign liver tumors are diagnosed because of symptoms or complications, and require urgent management including surgery as a major ...

Liver biochemistry (usually normal in cases of benign, uncomplicated tumors), viral serologies, and tumor markers are useful for excluding liver disease or with atypical presentations. The ...

A group of researchers at VCU Massey Comprehensive Cancer Center was awarded $13 million by the National Cancer Institute.

Biomarker NBR1 shows promise in predicting liver cancer patients' response to immunotherapy, potentially improving treatment ...

Currently, there are a few available treatment options for liver cancer, including a combination of immunotherapies and a class of drugs known as tyrosine kinase inhibitors (TKIs), but their long-term ...

Doctors at the Cleveland Clinic are now using a new non-invasive approach to kill the tumors and keep patients alive.

A group of highly experienced researchers at VCU Massey Comprehensive Cancer Center was awarded more than $13 million through ...

The #HOPE4LIVER trials, testing the safety efficacy of histotripsy as a treatment for primary and metastatic liver tumors, met its goals for technical success and safety. The result, published in ...

It may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit ...

Researchers at Weill Cornell Medicine have made a breakthrough in the fight against liver cancer, by identifying a biomarker ...